YMFOcare: The impact of providing feedback on patients* symptoms and health-related quality of life and offering a self-management website on the self-management of patients with lymphoma. A randomized controlled population-based registry trial.

Completed

• Conditions: haematological malignancy; Hodgkin and non-Hodgkin lymphoma; 10025323

• Registration Number: NL-OMON42473
• Lead Sponsor: Integraal Kankercentrum Nederland (IKNL)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 500

Inclusion Criteria

All patients (men and women) that are newly diagnosed with Hodgkin or non-Hodgkin lymphoma in one of the participating hospitals and were 18 years or older at time of diagnosis.

Exclusion Criteria

Unable to complete a Dutch questionnaire.
Patients with severe psychopathology or dementia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>self-management and psychological distress.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Anxiety and depression, health care utilization, psychological empowerment,<br /><br>health-related quality of life (HRQoL) generic and specific, symptoms, illness<br /><br>perceptions, personal control, coping, satisfaction with information provision,<br /><br>remoralization, and fatigue.</p><br>